Molecular biology tools for precision medicine in managing lung cancer.

about

Molecular biology tools for precision medicine in managing lung cancer.

Item

http://www.wikidata.org/entity/Q49658290

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Molecular biology tools for precision medicine in managing lung cancer.

@en

Molecular biology tools for precision medicine in managing lung cancer.

@nl

type

Item

label

Molecular biology tools for precision medicine in managing lung cancer.

@en

Molecular biology tools for precision medicine in managing lung cancer.

@nl

prefLabel

Molecular biology tools for precision medicine in managing lung cancer.

@en

Molecular biology tools for precision medicine in managing lung cancer.

@nl

P1476

Molecular biology tools for precision medicine in managing lung cancer.

@en

P2093

P A Mahesh

http://www.w3.org/2001/XMLSchema#string

P2860

Factors affecting 30-month survival in lung cancer patients

Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.

EGFR: The Paradigm of an Oncogene-Driven Lung Cancer

Bias-Corrected Targeted Next-Generation Sequencing for Rapid, Multiplexed Detection of Actionable Alterations in Cell-Free DNA from Advanced Lung Cancer Patients.

Epidermal growth factor receptor mutation in lung adenocarcinoma in India: A single center study.

Mutation-Enrichment Next-Generation Sequencing for Quantitative Detection of KRAS Mutations in Urine Cell-Free DNA from Patients with Advanced Cancers.

Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study.

Molecular biomarkers for lung adenocarcinoma.

Prospective Validation of Rapid Plasma Genotyping for the Detection of EGFR and KRAS Mutations in Advanced Lung Cancer.

Profiling Non-Small Cell Lung Cancer: From Tumor to Blood.

P304

1-3

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/LUNGINDIA.LUNGINDIA_470_17

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29319025

http://www.w3.org/2001/XMLSchema#string

P932

5760860

http://www.w3.org/2001/XMLSchema#string